160 related articles for article (PubMed ID: 9546683)
1. The relationship between pentosidine and hemodialysis-related connective tissue disorders.
Sakata S; Takahashi M; Kushida K; Oikawa M; Hoshino H; Denda M; Inoue T
Nephron; 1998; 78(3):260-5. PubMed ID: 9546683
[TBL] [Abstract][Full Text] [Related]
2. The advanced glycation endproduct, pentosidine, in the carpal ligament in patients with carpal tunnel syndrome undergoing hemodialysis: comparison with idiopathic carpal tunnel syndrome.
Takahashi M; Hoshino H; Kushida K; Murata H; Baba S; Inoue T
Nephron; 1998 Dec; 80(4):444-9. PubMed ID: 9832644
[TBL] [Abstract][Full Text] [Related]
3. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products and β(2)-microglobulin as predictors of carpal tunnel syndrome in hemodialysis patients.
Busch M; Schwenzky A; Franke S; Stein G; Wolf G
Blood Purif; 2012; 34(1):3-9. PubMed ID: 22699860
[TBL] [Abstract][Full Text] [Related]
5. Association between pentosidine and arteriosclerosis in patients receiving hemodialysis.
Kitauchi T; Yoshida K; Yoneda T; Saka T; Yoshikawa M; Ozono S; Hirao Y
Clin Exp Nephrol; 2004 Mar; 8(1):48-53. PubMed ID: 15067516
[TBL] [Abstract][Full Text] [Related]
6. Circulating level of alpha2-macroglobulin-beta2-microglobulin complex in hemodialysis patients.
Motomiya Y; Ando Y; Haraoka K; Sun X; Iwamoto H; Uchimura T; Maruyama I
Kidney Int; 2003 Dec; 64(6):2244-52. PubMed ID: 14633149
[TBL] [Abstract][Full Text] [Related]
7. Hemodialysis-related amyloidosis: Is it still relevant?
Kaneko S; Yamagata K
Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815
[TBL] [Abstract][Full Text] [Related]
8. Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.
Miyata T; Taneda S; Kawai R; Ueda Y; Horiuchi S; Hara M; Maeda K; Monnier VM
Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2353-8. PubMed ID: 8637877
[TBL] [Abstract][Full Text] [Related]
9. Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients.
Schiffl H
Hemodial Int; 2014 Jan; 18(1):136-41. PubMed ID: 23718290
[TBL] [Abstract][Full Text] [Related]
10. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients.
Stein G; Franke S; Mahiout A; Schneider S; Sperschneider H; Borst S; Vienken J
Nephrol Dial Transplant; 2001 May; 16(5):999-1008. PubMed ID: 11328907
[TBL] [Abstract][Full Text] [Related]
11. Cartilage biomarkers in hemodialysis patients and the effect of beta2-microglobulin on articular chondrocytes.
Sunk IG; Demetriou D; Szendroedi J; Amoyo L; Raffetseder A; Hörl WH; Sunder-Plassmann G; Smolen JS; Bobacz K
Osteoarthritis Cartilage; 2008 Nov; 16(11):1336-42. PubMed ID: 18457963
[TBL] [Abstract][Full Text] [Related]
12. Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients.
Furuya R; Kumagai H; Takahashi M; Sano K; Hishida A
Blood Purif; 2005; 23(4):311-6. PubMed ID: 15980621
[TBL] [Abstract][Full Text] [Related]
13. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels.
Tessitore N; Lapolla A; Aricò NC; Poli A; Gammaro L; Bassi A; Bedogna V; Corgnati A; Reitano R; Fedele D; Lupo A
J Nephrol; 2004; 17(5):707-14. PubMed ID: 15593039
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis.
Fagugli RM; Vanholder R; De Smet R; Selvi A; Antolini F; Lameire N; Floridi A; Buoncristiani U
Int J Artif Organs; 2001 May; 24(5):256-62. PubMed ID: 11420874
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
[TBL] [Abstract][Full Text] [Related]
16. Low parathyroid hormone and pentosidine in hemodialysis patients.
Panuccio V; Mallamaci F; Tripepi G; Parlongo S; Cutrupi S; Asahi K; Miyata T; Zoccali C
Am J Kidney Dis; 2002 Oct; 40(4):810-5. PubMed ID: 12324917
[TBL] [Abstract][Full Text] [Related]
17. Plasma pentosidine levels in uremic patients before and after hemodialysis.
Takahashi M; Kushida K; Ishihara C; Denda M; Inoue T
Scand J Urol Nephrol; 1995 Jun; 29(2):131-4. PubMed ID: 7569788
[TBL] [Abstract][Full Text] [Related]
18. Association of serum pentosidine with arterial stiffness in hemodialysis patients.
Zhou Y; Yu Z; Jia H; Sun F; Ma L; Guo R; Peng L; Cui T
Artif Organs; 2010 Mar; 34(3):193-9. PubMed ID: 20447043
[TBL] [Abstract][Full Text] [Related]
19. Dialysis-related amyloidosis of the heart in long-term hemodialysis patients.
Takayama F; Miyazaki S; Morita T; Hirasawa Y; Niwa T
Kidney Int Suppl; 2001 Feb; 78():S172-6. PubMed ID: 11169005
[TBL] [Abstract][Full Text] [Related]
20. The influence of gender, weight, height and BMI on pentosidine concentrations in plasma of hemodialyzed patients.
Slowick-Zylka D; Safranow K; Dziedziejko V; Dutkiewicz G; Ciechanowski K; Chlubek D
J Nephrol; 2006; 19(1):65-9. PubMed ID: 16523428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
